Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of parkinson’s disease

Frontiers in Cellular Neuroscience

Volumn 9, Issue June, 2015, Pages 1-11

  Visanji, Naomi P ^a   Sarvestani, Iman Kamali ^b,c   Creed, Meaghan C ^d   Shoaei, Zahra Shams ^b   Nobrega, José N ^d   Hamani, Clement ^d,e   Hazrati, Lili Naz ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deep brain stimulation; Parkinson s disease; Striatal medium spiny neurons; Subthalamic nucleus; Translational profile

Indexed keywords

NEUROTRANSMITTER;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEPTH STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; FATTY ACID METABOLISM; GENE EXPRESSION; GENE EXPRESSION ASSAY; MICROARRAY ANALYSIS; MOUSE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; REAL TIME POLYMERASE CHAIN REACTION; STRIATOPALLIDAL NEURON; SUBTHALAMIC NUCLEUS; TRANSLATING RIBOSOMAL AFFINITY PURIFICATION;

EID: 84935915934     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00221     Document Type: Article

References (43)

1. Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., and Haroutunian, V. (2010). Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. Brain Res. 1318, 167-177. doi: 10.1016/j.brainres.2010.01.006
2. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375. doi: 10.1016/0166-2236(89)90074-X
3. Bae, B. I., Hara, M. R., Cascio, M. B., Wellington, C. L., Hayden, M. R., Ross, C. A., et al. (2006). Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc. Natl. Acad. Sci. U.S.A. 103, 3405-3409. doi: 10.1073/pnas.0511316103
4. Baker, R. W., Jeffrey, P. D., and Hughson, F. M. (2013). Crystal structures of the Sec1/Munc18 (SM) protein Vps33, alone and bound to the Homotypic Fusion and Vacuolar Protein Sorting (HOPS) subunit Vps16*. PLoS ONE 8:e67409. doi: 10.1371/journal.pone.0067409
5. Brand, F., et al. (2012). The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology. Mol. Cell. Biol. 32, 2467-2478. doi: 10.1128/MCB.06633-11
6. Cenci, M. A., and Lundblad, M. (2007). Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson’s disease in rats and mice. Curr. Protoc. Neurosci. Chapter 9, Unit 9.25. doi: 10.1002/0471142301.ns0925s41
7. Chen, N., and Napoli, J. L. (2008). All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J. 22, 236-245. doi: 10.1096/fj.07-8739com
8. Choi, J., et al. (2005). Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases J. Neurosci. 25, 869-879. doi: 10.1523/JNEUROSCI.3212-04.2005
9. Chuang, D. M., Hough, C., and Senatorov, V. V. (2005). Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45, 269-290. doi: 10.1146/annurev.pharmtox.45.120403.095902
10. Connolly, B. A., Rice, J., Feig, L. A., and Buchsbaum, R. J. (2005). Tiam1-IRSp53 complex formation directs specificity of rac-mediated actin cytoskeleton regulation. Mol. Cell. Biol. 25, 4602-4614. doi: 10.1128/MCB.25.11.4602-4614.2005
11. Cousins, S. L., Innocent, N., and Stephenson, F. A. (2013). Neto1 associates with the NMDA receptor/amyloid precursor protein complex. J. Neurochem. 126, 554-564. doi: 10.1111/jnc.12280
12. Day, M., et al. (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259.doi: 10.1038/nn1632
13. Doyle, J. P., et al. (2008). Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749-762. doi:10.1016/j.cell.2008.10.029
14. Fasano, A., Aquino, C. C., Krauss, J. K., Honey, C. R., and Bloem, B. R. (2015) Axial disability and deep brain stimulation in patients with Parkinson disease. Nat. Rev. Neurol. 11, 98-110. doi: 10.1038/nrneurol.2014.252
15. Fasano, A., Daniele, A., and Albanese, A. (2012) Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol. 11, 429-442. doi: 10.1016/S1474-4422(12)70049-2
16. Follett, K. A. (2004). Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg. Focus 17:E3. doi: 10.3171/foc.2004.17.1.3
17. Forno, L. S. (1996). Neuropathology of Parkinson’s disease. J. Neuropathol. Exp. Neurol. 55, 259-272. doi: 10.1097/00005072-199603000-00001
18. Franklin, K., and Paxinos, G. (2007) The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic press
19. Gissen, P., et al. (2005). Comparative evolutionary analysis of VPS33 homologues: genetic and functional insights. Hum. Mol. Genet. 14, 1261-1270. doi: 10.1093/hmg/ddi137
20. Hamani, C., Diwan, M., Isabella, S., Lozano, A. M., and Nobrega, J. N. (2010). Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J. Psychiatr. Res. 44, 683-687. doi: 10.1016/j.jpsychires.2009.12.010
21. Hamani, C., and Nobrega, J. N. (2012). Preclinical studies modeling deep brain stimulation for depression. Biol. Psychiatry 72, 916-923. doi: 10.1016/j.biopsych.2012.05.024
22. Hammond, C., Ammari, R., Bioulac, B., and Garcia, L. (2008) Latest view on the mechanism of action of deep brain stimulation. Mov. Disord. 23, 2111-2121. doi: 10.1002/mds.22120
23. Heiman, M., et al. (2008). A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738-748. doi:10.1016/j.cell.2008.10.028
24. Heiman, M., et al. (2014) Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc. Natl. Acad. Sci. U.S.A. 111, 4578-4583 doi: 10.1073/pnas.1401819111
25. Je, H. S., et al. (2012).Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses. Proc. Natl. Acad. Sci. U.S.A. 109, 15924-15929. doi: 10.1073/pnas.1207767109
26. Kaltenbach, L. S., et al. (2007). Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3:e82. doi: 10.1371/journal.pgen.0030082
27. Karasinska, J. M., and Hayden, M. R. (2011) Cholesterol metabolism in Huntington disease. Nat. Rev. Neurol. 7, 561-572. doi: 10.1038/nrneurol.2011.132
28. Kita, T., and Kita, H. (2012). The subthalamic nucleus is one of multiple innervation sites for long-range corticofugal axons: a single-axon tracing study in the rat. J. Neurosci. 32, 5990-5999. doi: 10.1523/JNEUROSCI.5717-11.2012
29. Kopell, B. H., Rezai, A. R., Chang, J. W., and Vitek, J. L. (2006). Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson’s disease. Mov. Disord. 21(Suppl. 14), S238-S246. doi: 10.1002/mds.20958
30. Lang, A. E., and Lozano, A. M. (1998). Parkinson’s disease. First of two parts. N. Engl. J. Med. 339, 1044-1053. doi: 10.1056/NEJM199810083391506
31. Li, S., Arbuthnott, G. W., Jutras, M. J., Goldberg, J. A., and Jaeger, D. (2007) Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation. J. Neurophysiol. 98, 3525-3537. doi: 10.1152/jn.00808.2007
32. Lovinger, D. M., and Mathur, B. N. (2012) Endocannabinoids in striatal plasticity. Parkinsonism Relat. Disord. 18(Suppl. 1), S132-S134. doi: 10.1016/S1353-8020(11)70041-4
33. Macchi, B., Di Paola, R., Marino-Merlo, F., Felice, M. R., Cuzzocrea, S., and Mastino, A. (2015). Inflammatory and cell death pathways in brain and peripheral blood in Parkinson’s disease. CNS Neurol. Disord. Drug Targets.14, 313-324. doi: 10.2174/1871527314666150225124928
34. Molnar, E. (2013). Are Neto1 and APP auxiliary subunits of NMDA receptors? J. Neurochem. 126, 551-553. doi: 10.1111/jnc.12339
35. Montgomery, E. B., and Gale, J. T. (2008). Mechanisms of action of deep brain stimulation(DBS). Neurosci. Biobehav. Rev. 32, 388-407. doi: 10.1016/j.neubiorev.2007.06.003
36. Ng, D., et al. (2009). Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning. PLoS Biol. 7:e41. doi: 10.1371/journal.pbio.1000041
37. Oyang, E. L., Davidson, B. C., Lee, W., and Poon, M. M. (2011). Functional characterization of the dendritically localized mRNA neuronatin in hippocampal neurons. PLoS ONE 6:e24879. doi: 10.1371/journal.pone.0024879
38. Paxinos, G., and Franklin, K. (2004). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press
39. Postigo, A. A. (2003) Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J. 22, 2443-2452. doi: 10.1093/emboj/cdg225
40. Reiner, A., Hart, N. M., Lei, W., and Deng, Y. (2010) Corticostriatal projection neurons-dichotomous types and dichotomous functions. Front. Neuroanat. 4:142. doi: 10.3389/fnana.2010.00142
41. Rousseau, J., et al. (2010). Targeted inactivation of Mapk4 in mice reveals specific nonredundant functions of Erk3/Erk4 subfamily mitogen-activated protein kinases. Mol. Cell. Biol. 30, 5752-5763. doi: 10.1128/MCB.01147-10
42. Steiner, H., and Gerfen, C. R. (1998). Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123, 60-76. doi: 10.1007/s002210050545
43. Visanji, N. P., Virtanen, C., and Hazrati, L.-N. (2012) "Translational profiling reveals novel gene expression changes in the direct and indirect pathways in a mouse model of L-DOPA-induced dyskinesia," in Sixteenth International Congress of Parkinson’s Disease and Movement Disorders (Dublin: John Wiley & Son), S1-S523